Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kernal Biologics

Request full access

Creates mRNA therapies that instruct specific cells on how to make their own medicine

Cambridge, United StatesFounded 2016Biotech & Life Sciences

About Kernal Biologics

Kernal Biologics, based in Cambridge, MA, specializes in developing onco-selective mRNA therapeutics. The company operates in the biotechnology sector, focusing on creating advanced treatments for cancer and infectious diseases like COVID-19. Kernal Biologics serves healthcare providers, research institutions, and pharmaceutical companies. Its business model revolves around leveraging proprietary design and manufacturing processes to produce mRNA therapies that evade RNA sensors and enable cell-specific therapeutic protein expression. This approach aims to make treatments more effective, tolerable, and affordable. Revenue is generated through partnerships, grants, and sales of its mRNA platforms and therapies. The company has received multiple awards, including Amgen's Golden Ticket, and is recognized for its innovative use of synthetic biology and deep learning algorithms to enhance mRNA design.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2016
Headquarters
Cambridge, United States
Employees
22
Open positions
2
Dealroom signal
89.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Genetics and genomics, Spinout, Biotech and Pharma, mRNA Medicines, YC S20, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANT✓Other financing Oct 2025 — — Advanced Research Projects Agency for Health - ARPA-H ↗
SERIES A✓Equity / VC Jul 2022 $25M $100M Civilization Ventures · HBM Genomics · Amino Collective · Hummingbird Ventures ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Kernal Biologics website traffic

Latest recorded traffic for Kernal Biologics is 3.7K monthly website visits, up 105.6% over the last three months. Kernal Biologics's team grew 57.1% over the past year.

Latest monthly visits3.7K 3-month web change+105.6% 1-year team growth+57.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Kernal Biologics in the Cambridge ecosystem

Live from Dealroom

The Kernal Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

26 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Boeing
  • ISS National Lab
  • Y Combinator
  • Advanced Research Projects Agency for Health - ARPA-H

Series A6 investors entered at this stage

  • Outsized Ventures
  • Hummingbird Ventures
  • Civilization Ventures
  • HBM Genomics
  • Amino Collective
  • Amgen Ventures

Other known investors16 additional known investors

  • Harvard University
  • Massachusetts Institute of Technology
  • MassChallenge
  • Big Bang Ventures
  • Bluelotus
  • Calm Ventures
  • DO Venture Partners
  • FoundersX Ventures
  • frank malek
  • Helen Liang
  • HOF Capital
  • Luminous Ventures
  • MCMA Ventures
  • Scale Asia Ventures
  • SymBiosis
  • Wally Wang
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Kernal Biologics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kernal Biologics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.